Zura Bio Ltd

ZURA Nasdaq CIK: 0001855644

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation Cayman Islands
Business Address 4225 EXECUTIVE SQUARE, LA JOLLA, CA, 92037
Mailing Address 4225 EXECUTIVE SQUARE, LA JOLLA, CA, 92037
Phone 858-247-0520
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

-$52.40M
Net Income

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
10-K Annual financial report March 19, 2026 View on SEC
8-K Current report of material events March 19, 2026 View on SEC
8-K Current report of material events March 10, 2026 View on SEC
3 Initial insider ownership report March 5, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC

Annual Reports

10-K March 19, 2026
  • Signed agreements with major drug companies (Lilly, Pfizer, Lonza, Wuxi Biologics) for drug validation, funding, expertise, and manufacturing.
  • Developing a pipeline of drugs for inflammatory and autoimmune diseases, including Tibulizumab, Crebankitug, and Torudokimab.
View Analysis

Material Events

8-K Other March 19, 2026
High Impact
  • Successfully raised $144 million (net $134.8 million) through a public stock offering.
  • Cash runway extended through at least the end of 2028, significantly reducing financial risk.
View Analysis

Insider Trading

BUY 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.